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Background. Control of visceral leishmaniasis (VL) on the Indian subcontinent relies on prompt detection and treatment of 
symptomatic cases. Detection efforts influence the observed VL incidence and how well it reflects the underlying true incidence. 
As control targets are defined in terms of observed cases, there is an urgent need to understand how changes in detection delay and 
population coverage of improved detection affect VL control.
Methods. Using a mathematical model for transmission and control of VL, we predict the impact of reduced detection delays 
and/or increased population coverage of the detection programs on observed and true VL incidence and mortality.
Results. Improved case detection, either by higher coverage or reduced detection delay, causes an initial rise in observed VL in-
cidence before a reduction. Relaxation of improved detection may lead to an apparent temporary (1 year) reduction in VL incidence, 
but comes with a high risk of resurging infection levels. Duration of symptoms in detected cases shows an unequivocal association 
with detection effort.
Conclusions. VL incidence on its own is not a reliable indicator of the performance of case detection programs. Duration of 
symptoms in detected cases can be used as an additional marker of the performance of case detection programs.
Keywords.  visceral leishmaniasis; improved case detection; mortality; resurgence; transmission dynamics; mathematical 
modeling.
Visceral leishmaniasis (VL), also known as kala-azar, is a ne-
glected tropical disease caused by single-celled Leishmania 
parasites that are transmitted by sandflies [1]. On the Indian 
subcontinent, VL is considered entirely anthroponotic. Once 
infected, a small percentage of individuals develop symptoms 
that are fatal when left untreated. After successful treatment, 
5%–20% of cases develop a skin condition known as post–ka-
la-azar dermal leishmaniasis (PKDL), which lasts several years 
if left untreated [2]. Transmission is driven by cases of sympto-
matic infection and PKDL; asymptomatic cases most likely do 
not infect sandflies or to a much lower extent [3, 4].
The World Health Organization 2020 target for control of VL 
on the Indian subcontinent is defined as <1 detected VL case 
per 10 000 population per year at the (sub)district level (min-
imum 35 000 population; median size of 200 000) [5]. Control 
strategies rely on prompt detection and treatment of VL cases, 
and vector control in the form of indoor residual spraying of 
insecticide [5], although several studies question the impact of 
indoor residual spraying on VL incidence [6, 7]. Strategies to 
improve the promptness of detection include provision of diag-
nostics, raising clinical and community awareness, and more re-
cently, active case detection given that cases tend to be clustered 
in time and space [8, 9]. Detection success is generally meas-
ured through the average time between onset of symptoms and 
specific diagnosis, and this has reduced substantially, although 
it still shows substantial variability [10]. Given this variability, it 
is surprising that, to our knowledge, no consideration has been 
given to the impact of population coverage of improved detec-
tion programs and/or reductions in detection delay on achieve-
ment of control. It should also be noted that it is only possible to 
measure the diagnostic promptness in detected cases.
Given the drop in the number of VL cases on the Indian sub-
continent due to large-scale control efforts since 2010, achieve-
ment of the control target seems within reach in many regions 
[11–13]. However, if control efforts relax following the achieve-
ment of this target, the sustainability of VL control could be at 
stake [14]. Here, we hypothesize that in some situations, relax-
ation of detection efforts will lead to an apparent (temporary) 
achievement of the control target, whereas the true, underlying 
epidemiological situation is worsening. Such a relaxation could 
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occur through lack of clinical awareness, reduction in resources 
due to political complacency, or diversion of resources from de-
tection to another form of control.
Mathematical models of VL transmission are increasingly 
used for planning and assessing the efficacy of interventions 
and evaluating the intensity and timescale required to achieve 
set targets [13, 15]. In this study, we use a mathematical model 
for transmission and improved detection of VL to predict the 
impact of reduced detection delays and/or increased popula-
tion coverage of the detection programs on VL incidence and 
mortality.
METHODS
Model Structure
In this study, we employed a simplified version of earlier trans-
mission models [16–18], keeping only the processes in the 
model that are relevant to the impact of improved detection of 
VL cases. See Supplementary Appendix A for a schematic rep-
resentation of the model structure. In the model, susceptible 
individuals who are infected with the Leishmania parasite first 
enter a stage of latent infection, which is asymptomatic and 
noninfectious. Three percent of latent infections progress to 
developing symptomatic VL, which is diagnosable and infec-
tious, and the remainder recover without treatment [19]. The 
current definition of VL implies that individuals have clinical 
symptoms (fever) for 2 weeks prior to being diagnosable. Here, 
the detection and subsequent treatment of symptomatic cases 
were assumed to occur at a constant rate, so that the resulting 
distribution of detection delays reflects the high variation in 
reported treatment delays in India [20]. The competing risk of 
dying from untreated VL was assumed to increase with dura-
tion of symptoms, which was captured using the “linear chain 
trick” [21] to model progression until death as an Erlang dis-
tribution with shape 3. Together, the competing risks of being 
detected vs dying determine the proportion of VL cases that 
die undetected, the average time till death, and the duration 
of symptoms in the detected cases. A baseline situation with 
“standard” detection effort was defined as a situation in which 
half of the VL cases die undetected, and those who die have 
symptoms for an average duration of 150 days. These figures 
are completely unobserved but are consistent with reports 
of the case ascertainment [22, 23], and were uniquely repro-
duced by setting the baseline case detection rate to 365/243 
(ie, an average detection delay of 243 days in absence of ex-
cess mortality) and the annual mortality rate due to untreated 
VL to 365/189 (ie, an average duration until death of 189 days 
in absence of any detection effort). These rates translate to 
an average detection delay of about 8  months in absence of 
VL-related mortality, an average duration of symptoms before 
death of about 6 months in absence of any detection effort or 
healthcare-seeking behavior, and an average detection delay in 
detected cases of 92 days.
To simulate the potential impact of an improved detection 
program, we stratify the population of symptomatic cases into 2 
fractions: one covered by the improved detection program (ie, 
shorter treatment delay), and the other covered by the baseline 
detection rate. The 2 groups are subject to the same risk of dying 
from untreated VL. All detected VL cases are assumed to be 
successfully treated and reach the dormant stage, which lasts on 
average 21 months [24–26], after which most will recover com-
pletely. Five percent of individuals in the dormant stage will de-
velop PKDL [2], which lasts 5 years on average [24]. Individuals 
who recover fully from the dormant stage or PKDL are assigned 
to the fully recovered state, which we assume cannot be infected 
and lasts 5 years on average [18], after which they become sus-
ceptible again. Only VL cases and PKDL cases are considered 
to be infectious and contribute to transmission [3]. The back-
ground mortality rate due to other causes was based on the av-
erage expected lifespan at birth in rural Bihar, as reported for 
2010–2014 by the Indian Census Office [27]. We did not con-
sider age and population growth in our model, as these were not 
deemed relevant for the diagnostic process or VL transmission 
dynamics when predicting short-term trends.
The transmission rate was calibrated to represent a setting 
with observed (ie, detected) VL incidence of 5/10  000 capita 
(at equilibrium) before the start of improved detection, which 
for the baseline scenario translates to a true VL incidence of 
just over 10 cases/10 000/year and a mortality rate due to un-
treated VL of just over 5 cases/10 000/year. See Supplementary 
Appendix B for a formal description of the model equations, 
and Supplementary Appendix C for an overview of all biolog-
ical parameter values and relevant references.
We developed 2 model variants: a deterministic variant de-
fined in terms of a system of ordinary differential equations 
representing an infinitely large population, and a stochastic 
variant describing a discrete, finite set of individuals for whom 
transitions between disease stages are chance events based on 
the same transition rates as in the deterministic model var-
iant. Both variants assume a closed, fixed-size population 
and were implemented in pomp (version 2.2.2.0) [28] using 
R (version 3.6.0) and RStudio (version 1.2.1335) software. 
The model code can be accessed through a public online re-
pository at https://gitlab.com/erasmusmc-public-health/
vl-detection-effort-model.
Simulation Scenarios
First, we performed simulations with the deterministic model 
variant for various scenarios of improved detection, using a grid 
of values for population coverage of the improved detection 
strategy (0–100%, 1% increments) and reduction in detection 
delay among cases covered by the improved detection strategy 
(0–98%, 1% increments, relative to the baseline detection delay 
of 92 days). For each improved detection scenario, we predicted 
the true and observed VL incidence, mortality due to untreated 
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(ie, undetected) VL, and the average duration of symptoms in 
detected cases after 5 years of improved case detection.
Second, to predict the impact of a potential relaxation of de-
tection effort, we performed 10 000 stochastic simulations for 
a population size of 35 000 people (ie, the smallest block-level 
population size seen in the Indian subcontinent). Each sto-
chastic simulation was initiated using a multinomial sample of 
35 000 individuals with an expected state distribution as pre-
dicted for an equilibrium situation by the deterministic model 
variant before start of improved detection. Stochastic simu-
lations were run with improved detection implemented at 
80% population coverage with an achieved detection delay of 
37 days (ie, a 60% reduction). A relaxation in detection effort 
was defined as a lowering of population coverage from 80% to 
20%, while maintaining the achieved 60% reduction in detec-
tion delay, assuming that relaxation of detection effort does not 
affect the quality of the remaining effort because tools are still 
available and the healthcare workers are still primed. Relaxation 
of detection effort was assumed to occur in 2 situations: (1) after 
reaching the target of <1/10 000 observed VL cases for 3 consec-
utive years; or (2) after 5 years of improved control if program 
impact was unsatisfactory. For the first situation, we used the 
simulations that achieved the target for 3  years consecutively 
within 10 years of improved detection; the remainder of simu-
lations (ie, not reaching the target within 10 years) was used for 
the second situation. After relaxation of detection effort, simu-
lations were run for a further 5 years to monitor the changes in 
VL incidence (observed and true) and mortality.
RESULTS
Figure 1 illustrates the impact of improved case detection on 
VL incidence and mortality over the course of 10  years, as-
suming 80% population coverage. The true VL incidence and 
mortality due to untreated VL were predicted to decline sharply 
within the first 3 years (Figure 1A), reflecting the impact of im-
proved case detection on transmission. Observed VL incidence 
sharply increased during the first year of improved detection, 
approaching the true VL incidence, and then rapidly declined 
in the second and third year, followed by a stage of slow fur-
ther decline. The predicted average duration of symptoms in 
detected cases (Figure 1B) declined immediately with the start 
of improved detection and stabilized after 2 years.
Figure 2 summarizes the epidemiological situation after 
5 years of improved case detection for various levels of detec-
tion effectiveness, again starting from the same baseline situ-
ation. Settings with poorly performing detection programs are 
represented by a reduction in detection delay (y-axis) of 0% 
(ie, a 92-day detection delay as in the baseline scenario) and/
or 0% population coverage of the improved detection program 
(x-axis). In contrast, the top right corner of each panel repre-
sents a hypothetical ideal situation of maximum detection ef-
fectiveness in which the achieved treatment delays are shortest 
and the population coverage is highest. The solid circle in each 
panel represents the scenario depicted in Figure 1. Various 
combinations of program coverage and reductions in detec-
tion delay result in similar observed VL incidence (Figure 2A), 
with both parameters contributing approximately equally to the 
impact of improved case detection. Duration of symptoms in 
detected cases (Figure 2B) was predicted to decrease markedly 
with increasing program performance. A program coverage and 
a reduction in detection delay of both ≥60% ensured an overall 
detection delay of ≤50 days (among cases originating from both 
parts of the population covered and noncovered by improved 
detection). The difference between true VL incidence (Figure 
2C) and the observed VL incidence (Figure 2A) decreased 
with increasing program performance (ie, toward the top-right 
corner). Mortality due to untreated VL (Figure 2D) decreased 
strongly with increasing program performance. A  program 
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Figure 1. Deterministic model predictions for impact of improved case detection on visceral leishmaniasis (VL) incidence and mortality over time. Predictions reflect a set-
ting where, before the start of improved detection, the annual observed incidence of VL was 5/10 000 capita, and half of all cases died before detection. Improved detection 
is assumed to result in a reduction of detection delay down to 37 days (60% reduction from 92 days) in 80% of the population covered by the improved detection program.
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coverage and a reduction in detection delay of both ≥65% en-
sured a mortality rate of <1/10 000/year. When detection delays 
are short, then ensuring increased population coverage has rel-
atively more impact on reduction in mortality as demonstrated 
by the nearly vertical contour lines.
The stochastic version of the model highlights the impor-
tant impact of chance effects related to the achievement of the 
target. In 13% of 10 000 stochastic simulations, the incidence 
of observed VL fell below 1/10  000 for 3 consecutive years 
during the first 10  years of the improved detection program 
(Supplementary Appendix D, panel A). These simulations rep-
resent the left tail of the expected distribution of outcomes for 
which the mean is the incidence trend predicted by the deter-
ministic model (Figure 1). In the remaining 87% of simulations, 
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Figure 2. Contour plot of the model-predicted impact of 5 years of improved case detection at various levels of effectiveness on visceral leishmaniasis (VL). Model simula-
tions represent a setting where, before the start of improved detection, the annual observed incidence of VL was 5/10 000 capita, and half of all cases died before detection. 
Improved detection is defined in terms of the proportion of the population covered by the program (x-axis) and the reduction in detection delay in the part of the population 
covered by program (y-axis), relative to a reference delay of 92 days without improved detection. Contour lines represent combinations of program coverage and reductions 
in detection delay that result in the same outcome after 5 years of improved detection. Panels represent different outcome metrics that can be directly measured (A and B) 
or not directly measured (C and D). Outcome metrics are based on both the covered and noncovered parts of the population. The point at 80% population coverage and 60% 
reduction in detection delay represents the scenario depicted in Figure 1.
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the decline of the average VL incidence slowed down after 
3 years of improved detection (as in Figure 1).
Figure 3 illustrates the potential impact of relaxing detec-
tion effort on VL incidence and mortality after an initial period 
of improved case detection. When detection was relaxed after 
meeting the target (ie, in 13% of 10 000 simulations; blue line 
and shaded band), transmission was either interrupted (55% of 
13% of simulations with zero PKDL and VL cases), continued 
at levels with observed VL incidence <1/10 000 (18% of 13%), 
or resurged with observed VL incidence at or above 1/10 000 
(27% of 13%) within the next 5 years. The predicted outcomes 
are shown in more detail in Supplementary Appendix D. In the 
subset of simulations with “unsatisfactory” impact of improved 
detection (ie, 87% of 10 000 simulations; red line and shaded 
band), a relaxation of detection effort resulted in an increase in 
true VL incidence and mortality. In contrast, the observed VL 
incidence declined during the first year after relaxation, after 
which it increases again. In 13% of the 87% of simulations, the 
observed VL incidence dropped to <1/10 000/year in the first 
year after relaxation of the detection effort (ie, the point where 
the lower bound of the red shaded band crosses the dashed 
horizontal line).
DISCUSSION
Our results demonstrate 5 key principles of VL control programs 
on the Indian subcontinent. First, successful implementation of 
improved case detection is expected to temporarily increase the 
observed VL incidence. However, finding and treating cases re-
sults in reduction of transmission so that the true case incidence 
and mortality fall. Second, successful case detection requires 
that reduction in detection delays covers the whole popula-
tion. Third, there is an important role of chance in determining 
the likelihood of reaching and maintaining the control target. 
Fourth, when the control target is met, there is a high risk of re-
surgence of transmission if the detection effort is relaxed. Fifth, 
when little or no impact of improved detection is observed, a 
relaxation of the detection effort may result in a temporary re-
duction of observed VL incidence, sometimes even below the 
control target of 1/10 000/year, whereas the true VL incidence 
is actually increasing.
Clearly, observed VL incidence by itself is not a reliable indi-
cator of program performance, because it is closely related to the 
detection effort, such that relaxation may even incorrectly sug-
gest program improvement in the short run. Effective control 
has to be defined in terms of low case incidence combined with 
successful case detection and low average duration of symptoms. 
The presence of subpopulations who have longer detection de-
lays (due to, eg, lower healthcare access and/or lower disease 
awareness) are important barriers to effective control. Our re-
sults show that the duration of symptoms in observed VL cases 
could serve as an additional indicator as it is temporally more 
directly related to the performance of case detection programs. 
The pattern in Figure 1B shows that the decrease quickly plat-
eaus, which is not an indication that control is failing, but rather 
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Figure 3. Stochastic model predictions for the number of visceral leishmaniasis (VL) cases and deaths when detection effort is relaxed after an initial period of improved 
detection. Simulations represent a setting where, before the start of improved detection, the annual observed incidence of VL was 5/10 000 capita, and half of all cases died 
before detection. Improved detection was defined as an average detection delay that is reduced from 92 to 37 days in 80% of the population covered by the improved detec-
tion program (as in Figure 1 and the point in Figure 2). Next, the detection effort was relaxed, either after reaching the target of <1/10 000 observed VL cases for 3 consecutive 
years (blue line and shaded band), or after 5 years if program impact was unsatisfactory (red line and shaded band). Relaxation of detection effort was defined as a decrease 
in program coverage from 80% to 20%. Lines and shaded bands represent the median and 80% confidence intervals of annual numbers from multiple stochastic simulations.
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that detection effort is sustained. If the duration of symptoms in 
detected cases has not decreased significantly, then most likely 
the control target has only been seemingly (and temporarily) 
met because of poor case detection. Of course, the quality assur-
ance accuracy of reported detection delays remains challenging, 
given the fact that individuals often attend multiple clinics be-
fore being diagnosed with VL.
An independent measure of case detection effort and success 
(ie, if a case is there, will it be diagnosed and how long will it 
take) would underpin the current interventions. It would also 
avoid potential perverse incentives (eg, lowering detection effort 
or reporting fewer cases to reach the control target). Currently, 
there is no systematic data collection on measures of diagnostic 
effort (eg, number of suspected cases tested or number of cases 
of splenomegaly tested). Requiring programmatic reporting of 
such data would keep VL in the clinic focus even when there 
are zero cases, and would also provide denominators to esti-
mate the rate of VL detection. A  small proportion of PKDL 
cases arise without previous treatment, so reporting these sepa-
rately from PKDL cases with known VL history would provide 
a measure of the relative incidence of undiagnosed VL. Other 
approaches would require development of systems beyond the 
current program (eg, postmortem measurements), which are 
unlikely to be initiated solely for the VL program.
A successful detection program, in which most VL cases are 
diagnosed promptly, means that the observed VL incidence 
more accurately represents the true state of the population. In 
particular, if the VL incidence target is met due to reduction in 
transmission through diagnosis and treatment, then it is guar-
anteed that the true (unobserved) mortality due to VL is also 
low (Figure 2). A successful detection program involves many 
processes including community and clinical awareness, access 
to healthcare, and availability of diagnostics, and we have not 
included any of these details, but we show that it is important 
that reductions in detection delay have wide population cov-
erage. This is relevant when considering active case detection or 
other activities targeted to “hotspots,” and to ensure that they do 
not result in sections of the population with reduced detection 
that can continue to support transmission.
It has been recognized that VL diagnoses are clustered in 
time and space, and pursuing active case detection in commu-
nities in which further cases are expected exploits this epidemi-
ological observation. For instance, in India the control program 
focuses on finding febrile patients in the vicinity of index VL 
cases. Xeno-monitoring—that is, surveillance of vectors for 
presence of infection and infectiousness—is another avenue 
being actively considered. Given that there appears to be little 
transmission from asymptomatic cases, the presence of infected 
sandflies might be good evidence of a case of infectious VL or 
PKDL in the community. However, this needs to be confirmed.
Our deterministic model suggests that the observed VL in-
cidence cannot reach <1/10  000 within 5  years of improved 
control (Figure 2), but stochastic model predictions suggest that 
the control targets can be met in a proportion of situations with 
similar or lower VL incidence than considered here (precontrol 
annual VL incidence of 5/10 000 capita). The simulations also 
show that even when targets are achieved there is a chance of 
resurgence. This difference highlights the deficiency of deter-
ministic models to adequately capture stochastic effects in 
populations of finite size. Some of the parameters in the model 
have had to be inferred, so we focus our attention on the quali-
tative, rather than quantitative, results.
The achievement of the control target in various field set-
tings with similar or even higher precontrol VL incidence 
than considered may be explained by concomitant changes in 
human exposure to sandfly bites, for example, due to successful 
use of indoor residual spraying and/or other factors that affect 
sandfly biology, which were not considered in the model here. 
Conclusions with regard to (relaxation) of detection effort do 
not depend on the above factors.
We have assumed that transmission within the popula-
tion is homogeneous, that is, that each individual is equally 
likely to transmit to each other individual. This is a sim-
plification of reality, and given the role of relatively short-
range vectors, the transmission dynamics of VL are likely 
better captured by considering meta-populations (eg, popu-
lations of people within separate villages), and we are ac-
tively pursuing this hypothesis. How the processes we have 
studied here interact with transmission at multiple scales is 
not immediately clear, but we are confident that our under-
lying results are robust.
It is becoming clear that only VL and PKDL cases can transmit 
significantly to sandflies, but there remain many important pa-
rameter values, such as proportion developing different types 
of PKDL (nodular, popular, etc), their infectiousness, and their 
duration, for which good data are still accruing [3]. Similarly, 
the potential roles of longer-term immunity following VL and 
asymptomatic infection are largely unknown. However, these 
will largely influence longer-term dynamics, and the shorter-
term patterns that we explore here are dominated by 1 infection 
per host and do not include the recycling of hosts through the 
susceptible class.
In conclusion, we show that VL incidence on its own is 
not a reliable indicator of the performance of case detection 
programs. Unless transmission is truly interrupted, relaxa-
tion of detection effort will result in a temporary reduction 
of observed VL incidence while true VL incidence and mor-
tality rise immediately. Therefore, continued case detection is 
pivotal for sustained control of VL. Our findings indicate that 
the average duration of symptoms in detected cases is a useful 
indicator of the performance of case detection programs, al-
though there is also a need for independent measures of case 
detection effort, such as number of suspected cases screened 
for VL, to avoid perverse incentives.
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Supplementary Data
Supplementary materials are available at The Journal of Infectious 
Diseases online. Consisting of data provided by the authors to 
benefit the reader, the posted materials are not copyedited and 
are the sole responsibility of the authors, so questions or com-
ments should be addressed to the corresponding author.
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